Redefining High-Level Disinfection Through UV-C Innovation

Ultrasound imaging has become one of the most indispensable tools in modern healthcare. From emergency medicine and women’s health to fertility care and interventional procedures, ultrasound probes move constantly between patients, departments, and clinical environments. Yet behind this routine workflow lies one of healthcare’s most persistent operational and infection prevention challenges: High-Level Disinfection (HLD). For decades, healthcare organizations relied almost entirely on chemical-based disinfection methods to manage ultrasound probe reprocessing. While effective, those systems often introduced a different set of problems — lengthy processing times, complex workflows, chemical exposure risks, inconsistent documentation, staff training variability, and growing operational costs. In busy imaging departments where every minute affects patient throughput, those inefficiencies quietly accumulate across the healthcare system.
‍

Germitec set out to fundamentally change that process. Built on nearly two decades of UV-C research and development, the company has emerged as the leading innovator in automated UV-C High-Level Disinfection technology for compatible ultrasound probes. Its flagship solution, Chronos®, is helping healthcare organizations rethink how infection prevention, operational efficiency, and sustainability can work together within a single workflow. “For decades, chemicals were the only good answer to High-Level Disinfection. That era is over,” says Jose Da Gloria, CEO of Germitec. “Automated UV-C now delivers fast, chemical-free, compliant HLD for compatible ultrasound probes, and adoption is accelerating. UV-C is not simply improving what was available. It is revolutionizing the way HLD processing of ultrasound probes is managed. Large commercial healthcare systems are making the change and our recent inclusion in ECAT contract has made Chronos® available to all VA and DoD facilities.  This is proof that UV-C is the new standard for HLD of ultrasound probes.”
‍

What makes Germitec’s approach particularly significant is that the company is not simply introducing another infection prevention device. It is redesigning the operational structure of HLD itself. The company’s Chronos® delivers automated UV-C High-Level Disinfection in approximately 90 seconds through a streamlined three-step process: insert and identify the probe, launch the cycle with a single click, and automatically document the completed cycle through Germitrac electronic traceability software. The simplicity of that workflow addresses some of the industry’s most pressing pain points directly. Traditional chemical HLD systems often involve multi-step manual procedures, consumable management, drying processes, and extensive staff handling. Germitec eliminates chemicals entirely, removing procurement, storage, handling, and disposal requirements while also eliminating staff and patient exposure risks. The company’s patented Yuvee® technology platform forms the scientific foundation behind Chronos®. Developed specifically for healthcare environments, the platform utilizes controlled 254 nm UV-C energy within a reflective chamber designed to eliminate shadowing for compatible probes. Each disinfection cycle is independently verified before completion, ensuring the required validated threshold has been achieved rather than simply initiating the process.
‍

Germitec’s technology is validated to AOAC, compliant to ASTM High-Level Disinfection and supported by peer-reviewed evidence demonstrating efficacy against HPV-16, HPV-18, HIV, bacteria, fungi, mycobacteria, and spores. Chronos® also received FDA De Novo authorization in 2024 for commercialization in the US.  Germitec has maintained its CE marking since 2019 in Europe as a Class IIb device and manages an installed base with more than 2600 devices across 30 countries.
‍

Beyond clinical effectiveness, Germitec’s larger value proposition centers on operational transformation. Healthcare systems today face mounting pressures surrounding workforce sustainability, patient throughput, compliance management, and financial performance. In a recent Germitec-led survey of hospital C-suite leaders, respondents identified patient throughput, operational efficiency, and workforce sustainability among their highest organizational priorities. Chronos® was designed to directly support those enterprise-level objectives. The approximately 90-second automated cycle significantly improves probe availability, allowing imaging teams to reduce delays associated with traditional chemical HLD processing. Automated compliance documentation eliminates the burden of manual logging while reducing audit risks and workflow inconsistencies. Simplified training requirements also help healthcare organizations address staffing variability and onboarding challenges. “Our design philosophy starts with workflow, not technology,” Da Gloria explains. “We ask what clinicians, managers, and compliance teams need in a real clinical environment. Speed, simplicity, reliability, and traceability shaped every aspect of Chronos®.” That operational focus has helped Germitec gain traction across major healthcare systems, and Chronos® is now available across VA and DoD facilities within the United States. The company’s technology is currently used by leading fertility centers and healthcare organizations including Trinity Health, Intermountain Health, Tenet Health, UC Davis, Franciscan Health, Froedtert Health, and Unified Health.
‍

One of the company’s strongest differentiators is its extensive OEM compatibility ecosystem. Germitec has validated compatibility with all major OEMs through rigorous manufacturer-endorsed testing protocols. That compatibility matters enormously for large healthcare systems managing diverse probe fleets across multiple departments and facilities. Rather than forcing organizations to adopt fragmented workflows or multiple reprocessing systems, Germitec enables standardization at scale. “Health systems need solutions that work across their entire enterprise, not just within one department,” says Da Gloria. “Compatibility and scalability are critical to creating meaningful operational efficiency.”
‍

The company’s commitment to real-world implementation extends beyond the technology itself. Germitec works closely with healthcare organizations throughout the entire transition process, providing implementation planning, user training, workflow integration support, and operational guidance. Germitec’s team members average more than 25 years of experience across infection prevention and medical device industries. Their experience allows them to move beyond simply understanding the practical challenges healthcare providers face and help organizations achieve positive operational impact across a variety of healthcare environments.
‍

Germitec’s broader vision now extends beyond ultrasound probe disinfection alone. The company continues expanding the capabilities of the Yuvee® platform while investing heavily in OEM compatibility, clinical evidence generation, and global regulatory expansion. At its core, however, Germitec’s mission remains focused on solving a challenge that healthcare organizations have managed the same way for decades. By replacing lengthy chemical workflows with automated UV-C technology, the company is enabling healthcare systems to improve efficiency, strengthen compliance, reduce operational burdens, and create safer clinical environments — all while redefining what modern High-Level Disinfection can look like.

‍

Read article

‍

‍

‍